Rituximab for the treatment of autoimmune subepidermal blistering diseases

Dermatol Ther. 2018 Sep;31(5):e12687. doi: 10.1111/dth.12687. Epub 2018 Sep 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD20 / metabolism
  • Autoantigens / blood
  • Autoimmune Diseases / blood
  • Autoimmune Diseases / drug therapy*
  • B-Lymphocytes / metabolism
  • Collagen Type XVII
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Non-Fibrillar Collagens / blood
  • Retrospective Studies
  • Rituximab / therapeutic use*
  • Skin Diseases, Vesiculobullous / blood
  • Skin Diseases, Vesiculobullous / drug therapy*

Substances

  • Antigens, CD20
  • Autoantigens
  • Immunologic Factors
  • Non-Fibrillar Collagens
  • Rituximab